GWAS |
- Body mass index ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Epilepsy ( 30531953)
- Focal epilepsy ( 30531953)
- Generalized epilepsy ( 30531953)
- Metabolite levels ( 23823483)
- Obstructive sleep apnea trait (apnea hypopnea index) ( 29077507)
- Parkinson's disease ( 28892059)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
|
- Antidepressant treatment resistance (> 2 drugs prescribed) ( 30700811)
- Blood protein levels ( 30072576)
- Body mass index ( 26426971)
- Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging) ( 26252872)
- Dementia and core Alzheimer's disease neuropathologic changes ( 25188341)
- Metabolite levels (X-11787) ( 23934736)
- Motion sickness ( 25628336)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892)
- Pneumoconiosis in silica exposure ( 24986923)
- Protein quantitative trait loci ( 18464913)
|